Subscribe and recieve updates on this company.

Text STOCKS to 72727 for mobile alerts

We are excited to present LeMaitre Vascular, Inc. (NASDAQ: LMAT).

Full DD Report for LMAT

You must become a subscriber to view this report.

Recent News from (NASDAQ: LMAT)

3 Recession-Proof Dividend Growth Stocks You'll Want To Own During The Next Bear Market
(Source: imgflip ) With the bull market now being in its 10th year (and the longest in US history), plenty of investors are worried that another stock market crash is coming. And while the current risks of recession are very low , and chances are the next bear market is likely to be...
Source: SeekingAlpha
Date: September, 05 2018 12:18
LeMaitre Vascular, Inc. (LMAT) Management on Q2 2018 Results - Earnings Call Transcript
LeMaitre Vascular, Inc. (LMAT) Q2 2018 Earnings Conference Call July 26, 2018, 05:00 PM ET Executives Joseph P. Pellegrino - CFO David Roberts - President Analysts Joe Munda - First Analysis. Mike Petusky - Barrington Research Jim Sidoti - Sidoti & Company Brooks O'...
Source: SeekingAlpha
Date: July, 27 2018 00:14
LeMaitre Q2 2018 Record Sales $27.0mm (+5%), Record EPS $0.43 (+86%)
BURLINGTON, Mass., July 26, 2018 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT), a provider of vascular devices, implants and services, today reported Q2 2018 results, provided guidance and announced a $0.07/share dividend. Q2 2018 Results   Record sales of $...
Source: GlobeNewswire
Date: July, 26 2018 16:05
LeMaitre Vascular Will Announce Second Quarter 2018 Earnings Results on July 26, 2018
BURLINGTON, Mass., July 18, 2018 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it will release its second quarter 2018 financial results on Thursday, July 26, 2018, after the market close. The company has scheduled a conference call for 5:00 P...
Source: GlobeNewswire
Date: July, 18 2018 16:15
48 DGI Stocks Selected For Earnings Growth And Fundamental Strength
This is an improved version to my previous published watch lists that I created for my own IRA portfolio. The companies on this list have the following characteristics: Dividend Growth : All the stocks on this list are from David Fish's U.S. Dividend Champions list. To be included on t...
Source: SeekingAlpha
Date: June, 21 2018 08:39
LeMaitre Vascular to Present at the Jefferies Healthcare Conference on Friday, June 8, 2018
BURLINGTON, Mass., June 01, 2018 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that JJ Pellegrino, Chief Financial Officer, will present at the Jefferies Healthcare Conference on Friday, June 8, 2018 at the Grand Hyatt Hotel in New York, NY. The Company is sch...
Source: GlobeNewswire
Date: June, 01 2018 08:30
12 Upcoming Dividend Increases
Introduction The information presented below was created based on combining the "U.S. Dividend Champion" spreadsheet compiled by David Fish hosted here with upcoming dividend information from the NASDAQ . This meshes metrics about companies with dividend growth history with upcoming divid...
Source: SeekingAlpha
Date: May, 17 2018 10:18
Dividend Growth Portfolio: May 2018 Update
It has been about a year and a half since I retired and subsequently wrote my first Seeking Alpha article detailing my dividend growth portfolio. I had intended to write periodic articles detailing the portfolio updates and changes (as many other authors do here), but life events sidetracked m...
Source: SeekingAlpha
Date: May, 14 2018 18:44
LeMaitre Vascular, Inc. 2018 Q1 - Results - Earnings Call Slides
The following slide deck was published by LeMaitre Vascular, Inc. in conjunction with their 2018 Q1 earnings Read more ...
Source: SeekingAlpha
Date: April, 26 2018 14:45
Midday Gainers / Losers (04/26/2018)
Gainers: GNPX +81% . CRK +47% . VTVT +26% . CMG +24% . CCM +24% . MATR +22% . HZO +22% . UCTT +19% . PCMI +18% . AXSM +17% . More news on: Genprex, Inc, Comstock Resources Inc., vTv Therapeutics, Stocks on the move, , Read more ...
Source: SeekingAlpha
Date: April, 26 2018 12:40


Last 5 Days Trading Activity

DateOpen PriceClose PriceHighLowVolume

Last 5 Days Short Activity

DateShort VolumeTotal VolumeShort PercentageShort Indicator

* Short Mode

Short Analysis provided by Squeeze Report. Get a complete short report on LMAT.

About LeMaitre Vascular, Inc. (NASDAQ: LMAT)

Logo for LeMaitre Vascular, Inc. (NASDAQ: LMAT)

Not available


Contact Information



Current Share Structure

  • Market Cap: $646,578,315 - 05/11/2018
  • Issue and Outstanding: 19,312,375 - 05/01/2018


Recent Filings from (NASDAQ: LMAT)

Quarterly report with a continuing view of a company's financial position
Filing Type: 10-QFiling Source: edgar
Filing Date: May, 04 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: April, 25 2018
Official notification to shareholders of matters to be brought to a vote (Proxy)
Filing Type: DEF 14AFiling Source: edgar
Filing Date: April, 20 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: April, 05 2018
Annual report with a comprehensive overview of the company
Filing Type: 10-KFiling Source: edgar
Filing Date: March, 09 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: February, 21 2018
Amendment to the SC 13G filing
Filing Type: SC 13G/AFiling Source: edgar
Filing Date: February, 14 2018
Statement of beneficial ownership of common stock by certain persons
Filing Type: SC 13GFiling Source: edgar
Filing Date: February, 09 2018
Amendment to a previously filed 10-K
Filing Type: 10-K/AFiling Source: edgar
Filing Date: February, 08 2018
Amendment to the SC 13G filing
Filing Type: SC 13G/AFiling Source: edgar
Filing Date: January, 23 2018



Daily Technical Chart for (NASDAQ: LMAT)

Daily Technical Chart for (NASDAQ: LMAT)

Stay tuned for daily updates and more on (NASDAQ: LMAT)

It most certainly could but even more important is the recent overwhelming interest in the company. Check out Investors Hub and search on Twitter

More to come on (NASDAQ: LMAT)

Do your DD and if you choose, be ready to go!


The Research: All source information contained in this email is from the public sources mentioned below.



Thank you

DD Report



Disclaimer: DD Report publishes reports providing information on selected companies. DD Report is not a registered investment advisor or broker-dealer. This report is provided as an information service only, and the statements and opinions in this report should not be construed as an offer or solicitation to buy or sell any security. DD Report accepts no liability for any loss arising from an investors reliance on or use of this report. An investment in LMAT is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. DD Report has received no compensation for the publication and circulation of this report. DD Report does not own any shares of LMAT and does not buy, sell, or trade any shares of LMAT. This report contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Copyright 2018 by DD Report. All rights reserved. Our Full Disclaimer: